Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S6 from MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and Is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma
  1. Home
  2. Publications
  3. Supplementary Figure S6 from MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and Is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma

Supplementary Figure S6 from MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and Is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma

Authors:
  • SZShabir Zargar
    Shabir Zargar
  • PRPawan Kumar Raut
    Pawan Kumar Raut
  • HKHana Kim
    Hana Kim
  • SBSalah Boudjadi
    Salah Boudjadi
  • RHRachel A. Hoffman
    Rachel A. Hoffman
  • BSBenjamin Z. Stanton
    Benjamin Z. Stanton
  • FBFrederic G. Barr
    Frederic G. Barr

Open Access
Publisher website
Google Scholar
  • 3 November 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1541-7786.34897579
Abstract
Effects of miR-17-92 expression in Dbt wild-type and Dbt-iP3F cells.
Keywords
  • GENE REGULATION
  • MECHANISMS OF TRANSCRIPTION
  • ONCOGENIC TRANSCRIPTION FACTORS
  • ONCOGENES & TUMOR SUPPRESSORS
  • PEDIATRIC CANCERS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.